Promising use of nanotechnology in Pythium insidiosum: a systematic review
Authors:
- Lara Baccarin IaniskiLILara Baccarin Ianiski
- Aline Fontanella MacielAMAline Fontanella Maciel
- Caroline Quintana BragaCBCaroline Quintana Braga
- Carla WeiblenCWCarla Weiblen
- Daniela Isabel Brayer PereiraDPDaniela Isabel Brayer Pereira
- Luís Antônio SangioniLSLuís Antônio Sangioni
- Janio Morais SanturioJSJanio Morais Santurio
- Luciana PötterLPLuciana Pötter
- Sônia de Avila BottonSBSônia de Avila Botton
Open Access
- 1 January 2023
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Ciência Rural
- Vol. 53 (7)
Abstract
The aquatic oomycete Pythium insidiosum is an emerging pathogen highly relevant in human and veterinary medicine and an etiologic agent of pythiosis, a disease of worldwide distribution mainly affecting horses, dogs, and humans, presenting cutaneous, subcutaneous, ocular, gastrointestinal, and systemic forms. The available therapeutic methods to treat this disease and its forms are not entirely effective, thus highlighting the need to investigate the forms of treatments with better efficacy, such as compounds from different pharmacological classes, compounds of natural origin, and new technological alternatives, including nanotechnology. Therefore, this study evaluated scientific publications regarding the use of nanotechnology in P. insidiosum treatment. For this, a systematic literature review, was carried out on articles published from 2010 to 2022 on the LILACS, MEDLINE, Google Scholar, PubMed, and SciELO databases using the descriptors ‘Pythium insidiosum,’ ‘pythiosis,’ ‘nanotechnology,’ ‘nanoparticles,’ ‘nanoemulsion,’ and ‘treatment.’ We reported 162 articles for the researched theme; although, only four studies were included because they met the criteria established herein. A meta-analysis was used for the statistical analysis of the data obtained in vitro studies, and we reported the use of nanotechnology can be a promising alternative in developing antimicrobial compounds with anti-P. insidiosum activity. Nevertheless, additional research is needed to verify the potential use of this technology in clinical therapy against P. insidiosum infections.Keywords
This publication has 34 references indexed in Scilit:
- Canine Gastrointestinal Pythiosis Treatment by Combined Antifungal and Immunotherapy and Review of Published StudiesMycopathologia, 2013
- The Mammalian Pathogenic OomycetesCurrent Fungal Infection Reports, 2013
- Epidemiologia da pitiose equina na Região Sul do Rio Grande do SulPesquisa Veterinária Brasileira, 2012
- In vitro and in vivo susceptibility of two-drug and three-drug combinations of terbinafine, itraconazole, caspofungin, ibuprofen and fluvastatin against Pythium insidiosumVeterinary Microbiology, 2012
- Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imagingNanomedicine: Nanotechnology, Biology and Medicine, 2012
- In Vitro Susceptibility of Pythium insidiosum to Macrolides and Tetracycline AntibioticsAntimicrobial Agents and Chemotherapy, 2011
- Pythium insidiosum: An overviewVeterinary Microbiology, 2010
- In vitro activity of terbinafine associated to amphotericin B, fluvastatin, rifampicin, metronidazole and ibuprofen against Pythium insidiosumVeterinary Microbiology, 2009
- Clinical and Epidemiological Analyses of Human Pythiosis in ThailandClinical Infectious Diseases, 2006
- Equine pythiosis in Costa Rica: Report of 39 casesMycopathologia, 1986